Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Actavis reports positive results from ceftazidime-avibactam Phase III studies in cIAI patients

Actavis reports positive results from ceftazidime-avibactam Phase III studies in cIAI patients

Microbes influence human eating behavior, dietary choices

Microbes influence human eating behavior, dietary choices

Research roundup: Benefits of smaller practices; Rx price growth; fixing Medicare claims reviews

Research roundup: Benefits of smaller practices; Rx price growth; fixing Medicare claims reviews

Findings may lead to better ways for preventing gum disease, diabetes and Crohn's disease

Findings may lead to better ways for preventing gum disease, diabetes and Crohn's disease

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

VolitionRx installs automated liquid handling system to increase rate of blood sample analysis

VolitionRx installs automated liquid handling system to increase rate of blood sample analysis

Synthetic Biologics' SYN-005 antibody for Pertussis treatment to be highlighted at ICAAC 2014

Synthetic Biologics' SYN-005 antibody for Pertussis treatment to be highlighted at ICAAC 2014

Bacteria may depend more on gastrointestinal age than on environmental factors in babies

Bacteria may depend more on gastrointestinal age than on environmental factors in babies

New disposable device may help doctors to monitor post-operative ileus

New disposable device may help doctors to monitor post-operative ileus

High school recipients receive $2,500 to support digestive disease research projects

High school recipients receive $2,500 to support digestive disease research projects

New method of growing human cells may help develop tailor-made therapies for GI conditions

New method of growing human cells may help develop tailor-made therapies for GI conditions

Access Pharmaceuticals enters into exclusive license agreement with Norgine

Access Pharmaceuticals enters into exclusive license agreement with Norgine

Gut microbiome analysis has potential to be a new tool for noninvasive colorectal cancer screening

Gut microbiome analysis has potential to be a new tool for noninvasive colorectal cancer screening

African Americans less likely to engage in CRC screening in VA healthcare system

African Americans less likely to engage in CRC screening in VA healthcare system

Immunosuppressive drugs increase risk of myeloid disorders among IBD patients

Immunosuppressive drugs increase risk of myeloid disorders among IBD patients

Home based medical care for frail elders reduces Medicare costs by 17%

Home based medical care for frail elders reduces Medicare costs by 17%

PET-CT using FDG-labeled leucocytes may help in detecting infection in patients with acute pancreatitis

PET-CT using FDG-labeled leucocytes may help in detecting infection in patients with acute pancreatitis

New guideline recommends genetic testing of tumors for colorectal cancer patients

New guideline recommends genetic testing of tumors for colorectal cancer patients

Bacteria that aid in digestion help keep intestinal lining intact

Bacteria that aid in digestion help keep intestinal lining intact

Five-year $10.7M grant to study control, prevention of sexually-transmitted infections

Five-year $10.7M grant to study control, prevention of sexually-transmitted infections

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.